Literature DB >> 12673790

Characterization of 17 novel endoglin mutations associated with hereditary hemorrhagic telangiectasia.

Urszula Cymerman1, Sonia Vera, Amna Karabegovic, Salma Abdalla, Michelle Letarte.   

Abstract

Hereditary hemorrhagic telangiectasia type 1 (HHT1) is a vascular dysplasia caused by mutations in the endoglin (ENG) gene and associated with epistaxis, telangiectases, and a high incidence of pulmonary arteriovenous malformations. To efficiently detect deletions and insertions, we optimized a quantitative multiplex polymerase chain reaction (QMPCR) analysis. We report 17 novel mutations, of which six were detected by QMPCR. Three deletions occurring in intronic sequences were associated with a single copy of exons 9a-14, exon 5, and exons 7-8, respectively. A transient 70kDa monomeric mutant protein resulted from the in-frame deletion of exons 7 and 8 but no mutant protein was present in the other cases. Deletion (in exon 10) or insertion (in exon 7) of two nucleotides, as well as a 1-bp deletion in the small exon 9a were found by QMPCR. Sequencing was required to detect single nucleotide deletions/insertions in exons 2, 5, 6, and 8. No mutant proteins were associated with these frame shift mutations. Two novel splice site mutations resulted in skipping of exons 2 and 4, respectively, while a previously reported intron 3 splice mutant was observed as a de novo mutation. We also report five novel nonsense and missense mutations, including one de novo. Review of the 80 HHT1 families reported to date indicates that 10% would not be resolved by sequencing and that an additional 25% could be revealed by QMPCR performed prior to sequencing. Thus the use of QMPCR accelerates genetic screening for HHT1 and resolves mutations affecting whole exons. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673790     DOI: 10.1002/humu.10203

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

Review 1.  Pathogenesis of vascular anomalies.

Authors:  Laurence M Boon; Fanny Ballieux; Miikka Vikkula
Journal:  Clin Plast Surg       Date:  2011-01       Impact factor: 2.017

Review 2.  Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.

Authors:  Steffen K Meurer; Muhammad Alsamman; David Scholten; Ralf Weiskirchen
Journal:  World J Biol Chem       Date:  2014-05-26

3.  Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations.

Authors:  N L Prigoda; S Savas; S A Abdalla; B Piovesan; D Rushlow; K Vandezande; E Zhang; H Ozcelik; B L Gallie; M Letarte
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

4.  Clinical and analytical sensitivities in hereditary hemorrhagic telangiectasia testing and a report of de novo mutations.

Authors:  Friederike Gedge; Jamie McDonald; Amit Phansalkar; Lan-Szu Chou; Fernanda Calderon; Rong Mao; Elaine Lyon; Pinar Bayrak-Toydemir
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

Review 5.  Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.

Authors:  Africa Fernández-L; Francisco Sanz-Rodriguez; Francisco J Blanco; Carmelo Bernabéu; Luisa M Botella
Journal:  Clin Med Res       Date:  2006-03

Review 6.  Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.

Authors:  S A Abdalla; M Letarte
Journal:  J Med Genet       Date:  2005-05-06       Impact factor: 6.318

7.  Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients.

Authors:  T G W Letteboer; R A Zewald; E J Kamping; G de Haas; J J Mager; R J Snijder; D Lindhout; F A M Hennekam; C J J Westermann; J K Ploos van Amstel
Journal:  Hum Genet       Date:  2004-10-23       Impact factor: 4.132

8.  SMAD4 mutations found in unselected HHT patients.

Authors:  C J Gallione; J A Richards; T G W Letteboer; D Rushlow; N L Prigoda; T P Leedom; A Ganguly; A Castells; J K Ploos van Amstel; C J J Westermann; R E Pyeritz; D A Marchuk
Journal:  J Med Genet       Date:  2006-04-13       Impact factor: 6.318

9.  Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies.

Authors:  Carla Olivieri; Fabio Pagella; Lucia Semino; Luca Lanzarini; Cristina Valacca; Andrea Pilotto; Sabrina Corno; Susi Scappaticci; Guido Manfredi; Elisabetta Buscarini; Cesare Danesino
Journal:  J Hum Genet       Date:  2007-09-05       Impact factor: 3.172

10.  An intron mutation in the ACVRL1 may be associated with a transcriptional regulation defect in a Chinese family with hereditary hemorrhagic telangiectasia.

Authors:  Qian Yu; Xiao-Hui Shen; Ying Li; Rui-Juan Li; Ji Li; Yun-Ya Luo; Su-Fang Liu; Ming-Yang Deng; Min-Fei Pei; Guang-Sen Zhang
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.